Close
Funding for post-doctoral feasibility studies of 6-12 months duration is available to UK academics external to the Centre. These studies need to relate to the Centre vision but can span the full breadth of our remit.
These studies are encouraged to make use of Centre facilities and they should involve active collaboration with a Centre researcher.
The intention is that Centre involvement will help to bring these studies forward to a point where incorporation within the Centre programme is possible or where new funding opportunities are created. In this way these studies grow the capabilities of the Centre and its network of users.
The priority themes for feasibility studies are: Biophysical measurement New technologies and manufacturing strategies Modelling / Optimisation methodologies Life cycle cost analysis
- Biophysical measurement
- New technologies and manufacturing strategies
- Modelling / Optimisation methodologies
- Life cycle cost analysis
Download
- Further information on studies and the priority areas themes (pdf, 62kb)
- Proforma outline application form (pdf, 43.6kb)
In addition, the Centre will periodically issue calls for proposals on specific topics through the Open Call pages on the EPSRC website.
Feasibility studies funded since 2011
| Lead Investigator | Organisation | Title | Start Date | Value |
| Dr Jon Sussex | Office of Health Economics | Measuring expenditure on research into manufacturing | June 2012 | £29,000 |
| Dr Daryl Williams | Imperial College London | Protein crystallisation of Monoclonal Antibodies | May 2013 | £27,000 |
| Dr Oliver Hardick | University College London | Production and derivatisation of nanofibre adsorbents for high productivity purification | March 2013 | £20,000 |
| Prof. Mire Zloh | University of Hertfordshire | Molecular dynamics simulation of freeze drying processes: effects of excipients on protein structure and stability during freezing processes | April 2013 | £4,000 |
| Dr Stephanie Allen | University of Nottingham | Molecular Force Based Assays for the Prediction of Stability and Performance of Lyophilized Biopharmaceutical Formulations | April 2013 | £20,000 |
| Prof Alexander 'Sasha' Golovanov | University of Manchester | Protein biopharmaceuticals as NMR targets | March 2013 | £20,000
|
| Dr Jonathan Huddleston | Brunel University | Analytical Aqueous Phase Partitioning (AAPP) for the Biophysical Characterisation of Protein Isoforms/ adenovirus, liquid-liquid technology, scalability | Late 2013 | £30,000 |